Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. (300534.SZ) has announced that it has obtained a Medical Device Production License issued by the Gansu Provincial Medical Products Administration. The acquisition of this license signifies that the company's hemodialysis concentrate (powder) product is now qualified for both production and commercial sale. As a type of medical device used for hemodialysis, hemodialysis concentrate (powder) is widely applied in clinical settings for the treatment of acute renal failure and chronic renal failure.